GlassScriptPhysician profile
William Anthony Collazo
NPI 1649290594
$11,380.96
in general payments reported to CMS, 2019-2025
10 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,139 · 2020: $858 · 2021: $1,157 · 2022: $948 · 2023: $3,242 · 2024: $500 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,090 · Travel and Lodging: $1,172 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,090.08 |
| Travel and Lodging | $1,171.65 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,245.39 | 2019-2025 | Optis, Aveir, Gallant |
| Boston Scientific Corporation | $975.44 | 2019-2020 | |
| Medtronic Vascular, INC. | $621.66 | 2019-2020 | |
| Medtronic, INC. | $438.55 | 2021-2022 | |
| Abiomed | $429.82 | 2019-2023 | Impella |
| Shockwave Medical, INC | $253.76 | 2020-2021 | |
| Amgen INC. | $157.33 | 2019-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $149.87 | 2023 | Camzyos |
| Penumbra, INC. | $67.52 | 2023 | Indigo System |
| Chiesi USA, INC. | $41.62 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Collazo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.